Announcements Trials
Browse Landscape

Status

Terminated 1Suspended 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Trastuzumab 2Taxes 2Tamoxifen 2Interleukin-2 2Fluorouracil 2Cyclophosphamide 2Biopsy 2Anastrozole 2trastuzumab biosimilar HLX02 1taletrectinib 1palbociclib 1fluzoparib 1exemestane 1eribulin 1binimetinib 1aldesleukin 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tablets 1Receptors, Chimeric Antigen 1Radiotherapy 1Radiosurgery 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Tomography, Optical Coherence × Breast × Clear all
NCT02313116 2019-07-18

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Diagnostic Photonics, Inc.

Suspended
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡